avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tbp
|
ENSMUSG00000014767.10 | TATA box binding protein |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Tbp | mm10_v2_chr17_+_15499888_15499960 | 0.50 | 1.8e-03 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.8 | 26.4 | GO:0002148 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
8.3 | 24.8 | GO:0070488 | neutrophil aggregation(GO:0070488) |
5.0 | 19.9 | GO:0035524 | proline transmembrane transport(GO:0035524) glycine import(GO:0036233) |
4.5 | 13.5 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
4.2 | 12.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
3.9 | 11.8 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
3.9 | 31.5 | GO:0015671 | oxygen transport(GO:0015671) |
3.7 | 11.0 | GO:0002842 | positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
3.4 | 10.3 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
3.3 | 26.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
3.3 | 9.8 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
2.5 | 19.9 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
2.5 | 9.9 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
2.5 | 12.4 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
2.5 | 9.8 | GO:0021941 | negative regulation of cerebellar granule cell precursor proliferation(GO:0021941) |
2.3 | 21.1 | GO:0070944 | neutrophil mediated killing of bacterium(GO:0070944) |
2.3 | 18.4 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
2.2 | 6.6 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
2.1 | 8.5 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
2.0 | 4.0 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
2.0 | 25.5 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
1.9 | 23.4 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
1.9 | 5.8 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
1.8 | 12.7 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.7 | 12.2 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
1.6 | 4.8 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
1.5 | 40.2 | GO:0045109 | intermediate filament organization(GO:0045109) |
1.5 | 4.4 | GO:1901355 | response to rapamycin(GO:1901355) |
1.5 | 46.5 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
1.4 | 9.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.3 | 5.3 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
1.3 | 6.6 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
1.3 | 24.6 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
1.3 | 3.8 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
1.2 | 7.2 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
1.2 | 3.5 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
1.1 | 6.8 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
1.0 | 6.2 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
1.0 | 5.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
1.0 | 4.0 | GO:1902896 | terminal web assembly(GO:1902896) |
1.0 | 9.6 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
1.0 | 13.4 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.9 | 14.4 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.9 | 2.7 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.9 | 14.0 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.9 | 5.2 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.9 | 2.6 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.9 | 2.6 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.8 | 5.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.8 | 2.4 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.8 | 15.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.7 | 2.2 | GO:0046333 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.7 | 14.1 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.7 | 5.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.6 | 3.2 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.6 | 1.8 | GO:0071462 | cellular response to mercury ion(GO:0071288) cellular response to water stimulus(GO:0071462) |
0.6 | 8.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.6 | 2.3 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.5 | 3.2 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.5 | 3.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.5 | 7.1 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.5 | 3.5 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.5 | 2.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.5 | 0.9 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.4 | 5.8 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.4 | 2.7 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.4 | 1.2 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.4 | 55.6 | GO:0007586 | digestion(GO:0007586) |
0.4 | 7.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.4 | 2.7 | GO:1903026 | negative regulation of protein homodimerization activity(GO:0090074) negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.4 | 3.9 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.4 | 22.0 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.4 | 4.2 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.4 | 1.1 | GO:0009414 | hexitol metabolic process(GO:0006059) response to water deprivation(GO:0009414) inner medullary collecting duct development(GO:0072061) |
0.4 | 1.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.4 | 6.9 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.4 | 1.4 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.4 | 10.9 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.3 | 10.0 | GO:0031424 | keratinization(GO:0031424) |
0.3 | 3.6 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.3 | 2.1 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.3 | 2.3 | GO:0071816 | maintenance of unfolded protein(GO:0036506) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.3 | 9.3 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.3 | 2.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.3 | 12.8 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 3.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 3.9 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.2 | 0.7 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
0.2 | 1.7 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.2 | 7.4 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.2 | 1.3 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.2 | 1.5 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.2 | 1.5 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.2 | 6.1 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 0.5 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.2 | 8.3 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.2 | 0.6 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.2 | 14.0 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.2 | 2.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 11.2 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.2 | 5.0 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 6.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 1.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 5.5 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 4.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 2.7 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 2.5 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.1 | 2.7 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 0.6 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 1.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 18.4 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.1 | 11.9 | GO:0043627 | response to estrogen(GO:0043627) |
0.1 | 12.6 | GO:0006342 | chromatin silencing(GO:0006342) |
0.1 | 8.3 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) |
0.1 | 2.4 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.6 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
0.1 | 0.8 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 8.2 | GO:0061515 | myeloid cell development(GO:0061515) |
0.1 | 1.6 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 2.7 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 4.9 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.5 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 1.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.5 | GO:0051459 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 1.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.6 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.1 | 1.3 | GO:0031280 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) |
0.1 | 1.8 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 1.4 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.1 | 2.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.4 | GO:1901907 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.1 | 0.7 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 1.2 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.6 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.4 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.1 | 1.2 | GO:0007625 | grooming behavior(GO:0007625) |
0.1 | 5.2 | GO:0046546 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.0 | 0.4 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.0 | 1.5 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 2.3 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 1.8 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.0 | 0.4 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 2.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 1.2 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.0 | 2.6 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.9 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.7 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.7 | GO:0035690 | cellular response to drug(GO:0035690) |
0.0 | 0.1 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 2.1 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 1.4 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.0 | 2.2 | GO:0016331 | morphogenesis of embryonic epithelium(GO:0016331) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.0 | 56.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
4.6 | 18.4 | GO:0097450 | astrocyte end-foot(GO:0097450) |
2.6 | 26.4 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.8 | 28.3 | GO:0042581 | specific granule(GO:0042581) |
1.2 | 3.6 | GO:0005584 | collagen type I trimer(GO:0005584) |
1.2 | 6.9 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
1.1 | 2.2 | GO:0060205 | secretory granule lumen(GO:0034774) cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
1.1 | 12.2 | GO:0032982 | myosin filament(GO:0032982) |
1.0 | 36.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.9 | 4.5 | GO:0034715 | U7 snRNP(GO:0005683) pICln-Sm protein complex(GO:0034715) |
0.9 | 2.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.8 | 11.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.8 | 5.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.8 | 6.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.8 | 33.1 | GO:0000786 | nucleosome(GO:0000786) |
0.7 | 3.5 | GO:1990745 | EARP complex(GO:1990745) |
0.6 | 10.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.6 | 5.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.6 | 14.9 | GO:0042588 | zymogen granule(GO:0042588) |
0.6 | 4.0 | GO:1990357 | terminal web(GO:1990357) |
0.6 | 2.2 | GO:0032021 | NELF complex(GO:0032021) |
0.5 | 14.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.5 | 54.2 | GO:0005882 | intermediate filament(GO:0005882) |
0.5 | 1.6 | GO:0071007 | U2-type catalytic step 2 spliceosome(GO:0071007) |
0.5 | 2.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.5 | 11.0 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.5 | 1.4 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 1.8 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.4 | 2.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.4 | 2.4 | GO:0035976 | AP1 complex(GO:0035976) |
0.4 | 2.6 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.4 | 3.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.3 | 8.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 2.3 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 16.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 2.7 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 2.1 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.3 | 1.1 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.3 | 4.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 3.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 6.2 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 15.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 1.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 2.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 6.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 0.6 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 3.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 1.9 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 0.6 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.2 | 2.8 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 11.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 14.0 | GO:0005814 | centriole(GO:0005814) |
0.1 | 8.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 10.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 1.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 34.4 | GO:0030141 | secretory granule(GO:0030141) |
0.1 | 4.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 1.0 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 2.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 7.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 3.2 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 10.2 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 4.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 2.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 9.7 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.7 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 6.8 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 1.8 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 14.9 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.0 | 15.9 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 4.2 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 8.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 8.8 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 0.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 14.2 | GO:0030054 | cell junction(GO:0030054) |
0.0 | 3.1 | GO:0098590 | plasma membrane region(GO:0098590) |
0.0 | 9.0 | GO:0005730 | nucleolus(GO:0005730) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.1 | 56.4 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
9.8 | 9.8 | GO:0015254 | glycerol channel activity(GO:0015254) |
6.6 | 19.9 | GO:0005302 | L-tyrosine transmembrane transporter activity(GO:0005302) |
3.3 | 9.8 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
3.1 | 24.8 | GO:0050786 | Toll-like receptor 4 binding(GO:0035662) RAGE receptor binding(GO:0050786) |
2.5 | 9.8 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
2.2 | 10.9 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
2.1 | 10.7 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
2.1 | 12.6 | GO:0015265 | urea channel activity(GO:0015265) |
2.0 | 9.9 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
2.0 | 27.5 | GO:0016918 | retinal binding(GO:0016918) |
1.9 | 23.4 | GO:0008430 | selenium binding(GO:0008430) |
1.8 | 7.1 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
1.8 | 5.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
1.7 | 6.8 | GO:0001847 | opsonin receptor activity(GO:0001847) |
1.7 | 8.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.7 | 5.0 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
1.5 | 7.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
1.4 | 9.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.3 | 6.6 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
1.2 | 4.8 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
1.1 | 53.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
1.1 | 33.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
1.0 | 5.0 | GO:1990254 | keratin filament binding(GO:1990254) |
0.9 | 1.8 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.9 | 2.6 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.8 | 2.4 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.7 | 2.2 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.7 | 14.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.7 | 5.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.6 | 9.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.6 | 14.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.6 | 122.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.5 | 3.8 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.5 | 4.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.5 | 1.5 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.5 | 2.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.5 | 12.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.4 | 4.0 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.4 | 23.0 | GO:0004601 | peroxidase activity(GO:0004601) |
0.4 | 2.2 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.4 | 1.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.4 | 5.8 | GO:0048185 | activin binding(GO:0048185) |
0.4 | 2.7 | GO:0019808 | polyamine binding(GO:0019808) |
0.4 | 1.8 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.4 | 12.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 5.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.4 | 2.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 2.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 8.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.3 | 2.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 6.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.3 | 4.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.3 | 9.8 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.3 | 2.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.3 | 9.0 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.3 | 1.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.3 | 3.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 17.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 11.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 15.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 1.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 5.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.2 | 5.5 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.2 | 1.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 2.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 1.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 8.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.2 | 3.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 6.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 1.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.2 | 3.6 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 7.4 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 12.4 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 15.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 13.2 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 17.7 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 22.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 2.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 10.4 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 1.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 1.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.1 | 2.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 2.0 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 5.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 1.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 1.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.7 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 1.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 3.2 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.5 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.1 | 3.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 2.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 2.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.4 | GO:0034432 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.1 | 0.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 2.0 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 24.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 1.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 7.7 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 7.2 | GO:0019838 | growth factor binding(GO:0019838) |
0.1 | 1.5 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 3.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 2.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 3.2 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 2.8 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 9.5 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 0.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 1.8 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.9 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.9 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 5.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 10.2 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 2.2 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 5.1 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 3.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.0 | 0.6 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.6 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.4 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 5.4 | GO:0003682 | chromatin binding(GO:0003682) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 25.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.5 | 24.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 10.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 12.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 23.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 16.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 3.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 43.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 11.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 10.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 2.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 8.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 12.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 3.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 4.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 2.8 | PID ATM PATHWAY | ATM pathway |
0.1 | 2.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 2.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 2.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 11.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 5.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 3.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 2.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 1.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 2.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 2.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 7.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 2.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 17.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
1.5 | 24.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.0 | 51.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.0 | 20.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.8 | 9.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.7 | 10.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.7 | 11.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.6 | 9.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.6 | 15.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.5 | 27.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.5 | 16.0 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.5 | 18.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 14.8 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.4 | 10.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.4 | 16.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.4 | 4.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.4 | 11.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.3 | 18.6 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.3 | 16.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.3 | 6.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 4.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 4.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 3.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 5.9 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.2 | 10.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 2.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 3.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 2.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 5.3 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.1 | 1.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 1.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 1.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 2.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 5.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 7.0 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 3.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 14.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 2.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 1.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 1.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 2.0 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |